VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 559 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2015. The put-call ratio across all filers is 1.96 and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2015 | $10,948,000 | -20.0% | 61,374 | -0.3% | 0.28% | -28.4% |
Q2 2015 | $13,678,000 | +12.8% | 61,571 | +0.9% | 0.39% | +35.4% |
Q1 2015 | $12,121,000 | +37.0% | 61,026 | -1.3% | 0.29% | +29.3% |
Q4 2014 | $8,848,000 | +11.9% | 61,826 | +2.6% | 0.22% | +10.8% |
Q3 2014 | $7,910,000 | +10.0% | 60,288 | +5.7% | 0.20% | +10.9% |
Q2 2014 | $7,194,000 | -4.4% | 57,037 | -0.1% | 0.18% | -2.7% |
Q1 2014 | $7,524,000 | +1.1% | 57,071 | -10.0% | 0.19% | -3.6% |
Q4 2013 | $7,444,000 | +7.1% | 63,409 | -4.8% | 0.20% | 0.0% |
Q3 2013 | $6,949,000 | +25.4% | 66,608 | +3.4% | 0.20% | +18.9% |
Q2 2013 | $5,543,000 | – | 64,390 | – | 0.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |